Signet Financial Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Signet Financial Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-92	Closed	-$15K	–	424
2018 Q3	$15K	Sell	92 -48	-34%	-$7.26K	﹤0.01%	557
2018 Q2	$20K	Sell	140 -88	-39%	-$12.1K	﹤0.01%	526
2018 Q1	$30K	Buy	+228	New	+$31.1K	0.01%	430
2015 Q3	–	Sell	-2,496	Closed	-$310K	–	193
2015 Q2	$310K	Sell	2,496 -512	-17%	-$61.8K	0.07%	134
2015 Q1	$356K	Buy	+3,008	New	+$340K	0.1%	126

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Signet Financial Management's FBT Position: Q4 2018 in Review

Signet Financial Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 92 shares — an estimated $15K sold.

Signet Financial Management first reported a position in FBT in Q1 2015 and held it in 5 quarters. The position peaked at $356K in Q1 2015. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

Signet Financial Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
Signet Financial Management sold 92 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $15K.
Signet Financial Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 5 quarters.
Signet Financial Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $356K in Q1 2015.
194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Signet Financial Management's 13F filing for Q4 2018, filed 14 Feb 2019.